Emergent BioSolutions is making some major changes to its business and is laying off hundreds of employees in the process.
On Tuesday, Emergent announced that it is cutting back on its investment and “de-emphasizing” its growth in its CDMO services business.
The manufacturer will be reducing operations at its Bayview facility in Baltimore and its Canton, MA, location. Emergent said it’s also doing a small cut to its operations in Rockville, MD. This is due to changes in the “volume of US government procurements of medical countermeasures,” Emergent said in a news release. The company said it plans to keep some operations going at Bayview and Canton.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.